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Background. Critically ill patients appear to be at high risk of developing deep vein thrombosis 
(DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little 
is known about the clinical course of venous thromboembolism in the ICU setting. We therefore 
evaluated, through a systematic review of the literature, the available data on the impact of a diagnosis 
of DVT on hospital and ICU stay, duration of mechanical ventilation and mortality in critically ill 
patients. We also tried to determine whether currently adopted prophylactic measures need to be 
revised and improved in the ICU setting. 
Materials and methods. MEDLINE and EMBASE databases were searched up to week 4 of 
June 2012. Two reviewers selected studies and extracted data. Pooled results are reported as relative 
risks and weighted mean differences and are presented with 95% confidence intervals (CI).
Results. Seven studies for a total of 1,783 patients were included. A diagnosis of DVT was 
frequent in these patients with a mean rate of 12.7% (95% CI: 8.7-17.5%). DVT patients had longer 
ICU and hospital stays compared to those without DVT (7.28 days; 95% CI: 1.4-13.15; and 11.2 days; 
95% CI: 3.82-18.63 days, respectively). The duration of mechanical ventilation was significantly 
increased in DVT patients (weighted mean difference: 4.85 days; 95% CI: 2.07-7.63). DVT patients 
had a marginally significant increase in the risk of hospital mortality (relative risk 1.31; 95% CI: 
0.99-1.74; p=0.06), and a not statistically significant increase in the risk of ICU mortality (RR 1.64; 
95% CI: 0.91-2.93; p=0.10).
Conclusions. A diagnosis of DVT upon ICU admission appears to affect clinically important 
outcomes including duration of ICU and hospital stay and hospital mortality. Larger, prospective 
studies are warranted.
Keywords: deep vein thrombosis, critically ill patients, outcomes, meta-analysis.
Introduction
Critically ill patients are at high risk of developing 
venous thromboembolism (VTE) during their stay in 
the intensive care unit (ICU) because of the presence 
of several risk factors including premorbid medical 
and surgical conditions, invasive tests and treatments, 
prolonged immobility (often exacerbated by sedation 
or paralysis), vascular injury from indwelling 
central venous catheters, and acute and chronic renal 
insufficiency1. In addition, critical illness activates 
the coagulation cascade which may mediate the 
increased likelihood of VTE2-5. Thus, even when 
adequate antithrombotic prophylaxis is used, deep vein 
thrombosis (DVT) may occur in up to 10% of patients6. 
VTE in critically ill patients may be associated with 
significant morbidity, including prolonged requirement 
for ICU and hospital stay and, potentially, increased 
mortality7. 
The diagnosis of DVT and pulmonary embolism 
(PE) in critically ill patients is, for many aspects, 
problematic. The performance and interpretation 
of diagnostic tests for VTE, in particular for PE, in 
such patients is not well defined: critically ill patients 
frequently receive mechanical ventilation which reduces 
the utility of ventilation-perfusion lung scanning, they 
often have impaired renal function which may preclude 
intravenous contrast-based testing such as venography 
or computed tomography pulmonary angiography, the 
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use of pulmonary end-expiratory pressure may cause 
"false positive" venous ultrasounds, while large central 
venous catheters may impede blood flow and simulate 
a thrombus7.
Recent studies suggest that the prevalence of DVT on 
admission to a medical-surgical ICU may be as high as 
10%, and that the incidence of DVT developing during 
the ICU stay (based on systematic screening) ranges 
from 8% to 40% 6. These patients have an increased risk 
of developing PE. Unfortunately, only a few studies have 
systematically evaluated the incidence of PE in medical-
surgical patients with DVT. In a recent, relatively small 
study on ICU patients, 50% of patients with proximal 
lower limb DVT and 20% of patients with symptomatic 
upper limb venous thrombosis have asymptomatic PE 
at presentation8.
Although multiple criteria for the detection of early 
DVT have been developed, there is no consensus on the 
best method of screening and prevention in critically 
ill patients.
In contrast to the extensive documentation on the 
short and long-term outcomes of patients with DVT 
evaluated in other clinical settings, little is known about 
the clinical course of this disease in the ICU setting. 
The occurrence of DVT in ICU seems to be a prognostic 
marker of severity, although its causal relationship with 
the outcome is not well defined according to available 
studies. A comprehensive review of data could provide 
information to support the improvement of prophylactic 
measures, whether medical and/or mechanical, in order 
to avoid this frequent complication. Thus, to acquire 
additional evidence on the real impact of DVT in 
critically ill patients, we performed a meta-analysis of 
data available in the literature.
We hypothesized that both clinically undetected and 
clinically evident VTE would affect the prognosis of 
critically ill patients.
Materials and methods
Study identification
A systematic search of MEDLINE (1946 to week 
4 of June 2012), EMBASE (1980 to week 27 of 2012) 
was performed using the search terms "DVT", "venous 
thrombosis", "venous thromboembolism", "ICU", 
"intensive care unit", "medical-surgical ICU", "quality 
of life", "hospitalization length", "ICU stay", "hospitality 
mortality " "duration of mechanical ventilation", "ICU 
mortality", and "morbidity" both as medical subject 
headings and keywords.
Study selection
Two Authors (AM and YK) independently reviewed 
all selected titles and abstracts. Studies were excluded if 
the title and/or abstract was not appropriate for the aim of 
the current review. Full texts were subsequently obtained 
for eligible studies or when the relevance of an article 
could not be excluded with certainty. Disagreement was 
resolved by consensus and by opinion of a third reviewer 
(FD), if necessary.
English language studies were included if they met 
the following criteria: 
(i) the primary outcomes selected were: 
 a) duration of ICU or hospital stay, 
 b) ICU or hospital mortality, 
 c) duration of mechanical ventilation; 
(ii) the population consisted of adults (over 17 years of 
age) admitted to a medical-surgical ICU with a DVT 
diagnosed during the hospital stay or at admission 
to the ICU - patients receiving thromboprophylaxis 
at the time of DVT diagnosis were included in the 
current analysis; 
(iii) the study design was a prospective/retrospective 
cohort study or randomised clinical trials that 
investigated the influence of DVT on one or more 
of the following outcomes: hospital stay, ICU stay, 
duration of mechanical ventilation, and mortality. 
Studies providing outcomes without specific 
reference to patients with DVT were excluded.
If the required data could not be located in the 
published report, we attempted to obtain the necessary 
information by contacting the corresponding author. 
Studies not reporting the identified outcomes or without 
clear information on the analysis of the aforementioned 
outcomes were excluded. Studies were included when 
data were expressed as medians and interquartile ranges 
instead of means ± standard deviations. Patients with 
PE but without a documented DVT were excluded. The 
current analysis is focused mainly on DVT because PE 
is difficult to identify in patients in ICU. Finally, studies 
on patients with acute spinal cord injury or those who 
underwent neurosurgery were excluded. To assess the 
agreement between reviewers for study selection, we 
used the k statistic, which measures agreement beyond 
chance9.
Data extraction
Two investigators (AM and FD) independently 
extracted data from each study. Information on study 
characteristics, population characteristics and outcomes 
was extracted. Only cases of DVT were analysed. The 
outcomes evaluated in ICU patients with and without 
DVT were duration of mechanical ventilation, ICU stay 
and hospital stay, and total ICU and hospital mortality. 
Studies in which outcomes data could not be identified 
for extraction, and studies that evaluated hospitalised 
medical patients were excluded. Any disagreements 
between reviewers were resolved through discussion 
to reach consensus.
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Assessment of study validity
The same two unmasked investigators independently 
completed the assessment of study validity. Because 
the use of quality scoring systems or quality scales in 
observational studies is controversial10, we decided 
to assess study quality based on the type of study 
(prospective or retrospective) and selection of patients 
(consecutive enrolment without potential bias of 
selection). For each item fulfilled one point was given. 
A total of two points defined high-quality studies; one 
or less defined a low-quality study.
Given the characteristics of the included studies, 
the methodological quality of each study was also 
evaluated with the Newcastle-Ottawa Scale (NOS), 
which is specifically developed to assess the quality of 
non-randomised observational studies11. The scoring 
system encompasses the following eight items: clear 
definition of study sample, selection, interventions, 
outcomes, adequate assessment of the outcome, analyses 
for comparability, adequate length of follow-up, and 
appropriate interpretation of results. If an item was 
adequately addressed, 1 point each was awarded for the 
first seven specific items and 2 points for analyses for 
comparability. This results in a quality score between 
0 and 9. 
Data analysis
The weighted mean proportion of the rate of DVT 
(prevalence plus incidence) was calculated using a 
random-effects model. Associations between the 
presence of DVT and ICU and hospital mortality 
and the mean difference of duration of mechanical 
ventilation and of ICU and hospital stay in ICU 
patients with and without DVT were calculated 
using a random-effects model (the Der Simionan 
and Laird method)12. Pooled results are reported 
as odds ratio (OR) and weighted mean difference 
(WMD) and are presented with 95% confidence 
interval (CI) and with two-sided probability values. 
A probability value of 0.05 or less was considered 
statistically significant. 
The appropriateness of pooling data across studies 
was assessed using the Cochran Q and I2 test for 
heterogeneity, which measures the inconsistency across 
study results and describes the proportion of total 
variation in study estimates that is due to heterogeneity 
rather than sampling error13. Finally, funnel plots of 
effect size against standard error were completed, 
whenever possible, to assess for the presence of 
publication bias14.
We used Review Manager (RevMan; version 
5.0 for Windows; Oxford, England; The Cochrane 
Collaboration, 2008) and Stat Direct software (Version 
2.7; StatsDirect Ltd, Cheshire, UK) to pool data.
Results
Study identification and selection
We identified 926 potentially relevant studies from 
the following databases: 256 from Medline and 670 
from EMBASE (Figure 1). After screening the titles 
and abstracts, 870 were excluded using the predefined 
inclusion and exclusion criteria; the remaining 56 studies 
were retrieved for a more detailed evaluation. Manual 
review of references revealed two additional studies. 
Fifty of the 58 studies were subsequently excluded after 
detailed review of the full texts, leaving eight potentially 
appropriate articles15-23. One study was subsequently 
excluded since data were not presented in a manner that 
allowed extraction15-23. Therefore, seven studies were 
included in the current meta-analysis. Inter-observer 
agreement for study selection was good, with a k value 
of 0.74.
Study characteristics
Of the seven included studies,  five were 
prospective17-20,22, one was retrospective21 and one study 
was both prospective and retrospective16. Results of 
the study quality assessment according to the NOS are 
reported in Table I. The characteristics of the included 
studies are shown in Table II. DVT was diagnosed using 
Doppler ultrasonography (DUS) in three studies20-22, 
compression ultrasound (CUS) in three studies16-18 
and in one study it was diagnosed using CUS and/or 
                                                                                
Potentially relevant studies identified 
and 
screened for retrieval (n=917) 
Studies retrieved for a more detailed 
evaluation (n=56) 
Studies excluded after title  
and abstract screening  
with inclusion criteria (n=861) 
Not Reporting Required Outcomes  
(n=50) 
Potentially appropriate studies  
to be included in the meta-analysis (n=6) 
Additional studies evaluated by 
manual review of references (n=2) 
Potentially appropriate studies  
to be included in the meta-analysis (n=8) 
Studies included in the meta-analysis 
(n=7) 
Studies excluded  
after article screening  
according to inclusion criteria (n=1) 
Figure 1 - Study progression selection.
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venography19. In all the evaluated studies, screening 
for DVT was done in all patients irrespectively of 
clinical symptoms or suspicion. In two studies15,19 
routine screening of the lower extremities by CUS was 
performed within 48 hours of admission to the ICU, in 
four studies17,18,20,22 it was done every 7 days or sooner, 
clinically indicated and in one study16 screening was 
performed twice weekly. The study by Major et al. 
was excluded from this analysis since the presence of 
DVT was not systematically determined in the entire 
study population. PE was diagnosed using pulmonary 
angiography in three studies19,20,22 ventilation/perfusion 
lung scan in two studies19-22 and computed tomography 
pulmonary angiography in two other studies19,20. In 
contrast to the screening for DVT, these investigations 
were performed only when there was a clinical suspicion 
of PE. All seven studies evaluated the efficacy of 
thromboprophylaxis; unfractionated heparin (UFH) was 
used in four studies19-22, low molecular weight heparin 
(LMWH) in three studies17,20,22, UFH and LMWH in 
one study19 and a sequential compression device (SCD) 
in six studies16-18,20-22 (Table II). In all these studies, 
prophylaxis was started on admission to the ICU and 
continued throughout the ICU stay (thromboprophylaxis 
was primarily pharmacological, including UFH and 
LMWH, mechanical prophylaxis included pneumatic 
compression devices and anti-embolic stockings). The 
dosage and timing of prophylaxis were not clearly 
reported in all the analysed studies and it did not allow 
a specific analysis of this intervention.
Population characteristics
The number of the subjects enrolled in each study 
ranged from 110 to 714. The baseline characteristics 
of the populations are shown in Table IIIa and IIIb. 
Risk factors that may influence VTE risk, including 
underlying malignancy and APACHE II score or 
occurring during ICU stay (mechanical ventilation, use 
of inotropes/vasopressors and femoral venous catheters) 
were reported variably and not evaluated by all studies.
A total of 139 episode of DVT were detected in the 
1,163 included patients for a mean rate of 12.7% (95% CI: 
8.7-17.5%). The rate of DVT was similar when we 
excluded studies that evaluated the presence of DVT 
in ICU populations not receiving pharmacological or 
mechanical antithrombotic prophylaxis (mean rate 
12.0%; 95% CI: 7.8-16.9%).
Outcomes
Outcomes assessed during ICU stay in patients 
with and without DVT were tabulated; information on 
all relevant outcomes could not be obtained from all 
studies (Table IV). 
Duration of mechanical ventilation 
Four studies evaluated the duration of mechanical 
ventilation9,10,19 in patients with and without DVT (84 
and 670 patients, respectively). 
The duration of mechanical ventilation was 
significantly longer in patients with DVT than in those 
without DVT (WMD 4.85 days; 95% CI: 2.07, 7.63 
days; p=0.006). There was no heterogeneity among the 
studies (I2=0%; p=0.55) (Figure 2A). Due to the low 
number of studies, funnel-plot analysis could not be 
done. Publication bias could not, therefore, be assessed.
Duration of stay in hospital and the intensive care 
unit 
Three studies evaluated the duration of ICU stay and 
five studies the duration of hospital stay (84 patients with 
and 487 patients without DVT)12-14,18,20.
DVT patients spent a significantly longer time in 
the ICU than did patients without DVT (WMD 7.28 
days; 95% CI: 1.41-13.15 days; p=0.02). Heterogeneity 
among the studies was moderate, but not significant 
(I2 =47.9%; p=0.15) (Figure 2B). Due to the low number 
of studies, funnel-plot analysis could not be done. 
Publication bias could not, therefore, be assessed.
Hospital stay was significantly longer in DVT 
patients than in patients without DVT (WMD 11.2 days; 
95% CI: 3.82-18.63 days; p=0.003). Heterogeneity 
among the studies was significant (I2=73%; p=0.005) 
(Figure 2C,D). Funnel plot of WMD vs standard error 
appeared symmetric, suggesting absence of a publication 
bias. 
 
Intensive care unit and hospital mortality 
Five studies evaluated ICU mortality (96 patients 
with and 1474 patients without DVT)9,10,17,18. The data 
from the study by Boddi et al.16 were not published but 
were obtained on request from the Authors. 
DVT patients had a non-significant increased risk 
of ICU mortality compared to patients without DVT 
(RR 1.64; 95% CI, 0.91-2.93; p=0.10). Heterogeneity 
among the studies was marginally significant (I2= 53%; 
p=0.07) (Figure 2E). Funnel plot of RR versus standard 
error appeared symmetric, suggesting absence of a 
publication bias. 
Table I  - New Castle Ottawa Scale score of the analysed 
studies.
Study Score
Ibrahim21 (2002) 8
Velmahos22 (1998) 9
Major20 (2003) 4
Cook19 (2005) 8
Joynt17 (2006) 7
Khouli18 (2009) 5
Boddi16 (2010) 5
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Table IV - Outcomes.
Study Duration of mechanical 
ventilation in days 
(DVT vs no DVT)
Duration 
of hospitalisation 
in days (DVT vs no DVT)
ICU stay in days 
(DVT vs no DVT)
Hospital mortality rate 
(DVT vs no DVT) 
[95% confidence 
interval]
ICU mortality rate 
(DVT vs no DVT, n.) 
[95% confidence 
intervals]
Ibrahim21
(2002)
18.9±19.7 vs 14.6±12.9, 
p=0.310
31.4±21.7 vs 27.5±18.2, 
p=0.375
18.6±14.6 vs 15.9±1.04, 
p=0.388
8.9 (34.6%) vs 26.8 
(32.1), p=0.815
n/a
Velmahos22 
(1998)
Not given^ 49±32 vs 31±24, p<0.05 34±31 vs 19±18, p<0.05 n/a 31% (8) vs 18% (31), 
p= 0.04
Major20 
(2003)
n/a n/a n/a n/a 17% (2) vs 2% (15) 
p=0.03
Cook19 
(2005)
9** (4-25)* vs 6 (3-13)*, 
p=0.03
51** (24-73)* vs 23** 
(12-47)*, p<0.001
17.5** (8.5-30.5)* vs 9** 
(5,17)* 
17 (53.1%) vs 85 
(37.4%), p=0.04
-, 8** vs -, 62**, 
p=0.78
Joynt18 
(2006)
4 [0-14] vs 2 [0-46], 
p=0.81
0 [0-24] vs 0 [0-57], 
p=0.73
4 [5-21] vs 3 [2-61], 
p=0.89
5 (33%) vs 18 (28%), 
p=0.75
n/a
Khouli17 
(2009)
5.5 [2-20] vs 6 [1-36], 
p=0.90
n/a 8 [3-23] vs 8 [3-36], 
p=0.52
17% [5-51] 
vs 21% [10-23]; p=0.70
n/a
Boddi16 
(2010)
14.5 [6.5-19.75] vs 3 
[1-9], p=0.001
n/a 14 [9-26] vs 10 [7-29], 
p=0.05;
19 [13.5-30] vs 7 [4-15], 
p=0.001
n/a n/a
The fourth column (ICU stay in days) reports values as mean ± standard deviation, data on interquartile range (*) and median (**) are reported in the last 
four lines. Square brackets report 95% confidence intervals (CI). 
* Interquartile range; ** median; ^necessity for ventilation measured by positive end-expiratory pressure; -: missing value. DVT: deep vein thrombosis; 
vs: versus; ICU: intensive care unit.
Four studies evaluated hospital mortality (87 patients 
with and 505 patients without DVT)9,10,17,18 DVT patients 
had a non-significant increased risk of hospital mortality 
compared to patients without DVT (RR 1.31; 95% CI, 
0.99-1.74; p=0.06). There was no heterogeneity among 
the studies (I2=0%; p=0.88) (Figure 2E). Due to the low 
number of studies, funnel-plot analysis could not be 
done. Publication bias could not, therefore, be assessed.
Discussion
Our systematic review and meta-analysis of the 
literature confirms that DVT is not uncommon in 
ICU patients. Although DVT has potentially serious 
consequences, it is often unrecognised among ICU 
patients. Unfortunately, physical examination is not 
useful to rule out a diagnosis of DVT in these patients24. 
Concern about undiagnosed DVT in the ICU is justified 
by studies showing that 10% to 100% of DVT identified 
by screening ultrasound were clinically unsuspected, and 
it is possible that many mechanically ventilated patients 
with sudden episodes of hypotension, tachycardia, or 
hypoxia may have undetected PE25.
In this analysis, designed to explore the impact of 
a diagnosis of DVT on clinically important outcomes 
in the ICU, we were able to pool data from seven 
studies for a total of about 1,800 patients who met the 
predefined criteria. Statistically significant differences 
were found in ICU and hospital stay, duration of 
mechanical ventilation and hospital mortality between 
patients or without DVT. Furthermore, hospital mortality 
appeared to be marginally increased in DVT patients 
in comparison to patients without DVT. On the other 
hand, although there was a trend, ICU mortality was not 
significantly different between the two groups. However, 
these apparently negative results may be explained by 
the relatively low number of patients included in our 
meta-analysis. 
Our observations are important because the longer 
duration of stay and duration of mechanical ventilation 
contributes to increasing health care costs while higher 
rates of morbid outcomes, including duration of stay 
and death, are clearly of importance to patients in the 
ICU. Interestingly, DVT appears common in critically 
ill patients, despite the routine use of prophylactic 
measures, even when applied on admission.
The results of our systematic review may have 
important implications for clinical practice. In ICU 
patients, a DVT surveillance protocol may help in 
early identification of lower limb thrombi and can help 
in making decisions related to treatment to prevent 
progression to PE. However, the choice of the best 
screening test and the time of screening remain to be 
established. Venography is still considered the gold 
standard for the diagnosis of DVT, but this test is 
invasive and is not a cost-effective method for routine 
evaluation of DVT. Furthermore, the need for transport, 
positioning and dye exposure make this test problematic 
for most ICU patients. Ultrasonography is non-invasive 
and inexpensive26. However, the sensitivity of screening 
ultrasound for venous thrombosis in asymptomatic 
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Figure 2  - The impact of DVT.
 (A) In the ICU on duration of mechanical ventilation; (B) in the ICU on duration of ICU stay; (C) in the ICU on ICU mortality; (D) 
in the ICU on duration of hospital stay; (E) in the ICU on hospital mortality. DVT: deep vein thrombosis; ICU: Intensive Care Unit. 
(A)
(B)
(C)
(D)
(E)
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patients was found to be poor for both proximal and 
distal DVT, because it depends on the number of 
pathological compression manoeuvres documented in 
the ultrasound27.
In a prospective cohort study on ICU patients18, 
bilateral lower extremity compression ultrasound was 
performed within 48 hours of admission to the ICU, 
twice weekly, and if VTE was clinically suspected. In 
this study the authors found that the prevalence of DVT 
was 2.7% on ICU admission, and the incidence was 
9.6% during the ICU stay. A recent prospective study 
that applied the same ultrasound surveillance protocol, 
substantially confirmed these data15. Although the 
clinical implication of some of these events remains to be 
established, these results suggest the utility of multiple 
compression ultrasound examinations during ICU stay. 
Since DVT also occurred in patients on mechanical 
and pharmacological thromboprophylaxis, more 
effective preventive strategies seem to be necessary 
to reduce VTE in the critically ill population. 
However, bleeding complications also occurred 
relatively frequently in this setting, suggesting that 
thromboprophylaxis must be carefully considered 
in these patients. Unfortunately, in a recent large 
randomised controlled trial,  LMWH was not 
superior to UFH in decreasing the incidence of 
proximal DVT nor in reducing the incidence of major 
bleeding complications28, although the rate of PE was 
significantly lower with LMWH than with UFH (1.3 vs 
2.3%; hazard ratio, 0.51; 95% CI, 0.30-0.88; p=0.01) 
The best antithrombotic prophylaxis in this setting 
does, therefore, remain an unresolved issue.
Our analysis has several limitations: First, we 
cannot exclude important differences in baseline 
characteristics and in other concomitant risk factors 
in patients with and without DVT; thus several other 
clinical and non-clinical variables could have had an 
impact on the outcomes, and we could not adjust for 
them. Second, our systematic review was restricted 
to case-control studies, and the application of formal 
meta-analytic methods to observational studies is 
controversial, since bias implicit in the study design 
may misrepresent the strength of associations within 
the data10. To minimise this potential bias, we selected 
only studies in which the diagnosis of DVT was 
objectively confirmed. Third, the studies included in 
our meta-analysis had different inclusion and exclusion 
criteria, and combining results across studies may be 
inappropriate. However, the heterogeneity between the 
studies, calculated using the I2 statistic, was generally 
low. Furthermore, we decided to perform the analyses 
using the random-effects model, an approach that 
accounts for some of the variance between studies. 
Fourth, since it is recognised that publication bias can 
affect the results of meta-analyses, we attempted to 
assess this potential bias using a funnel plot. Funnel 
plots that considered ICU mortality and mean hospital 
stay appeared symmetric, suggesting the absence of 
publication bias for these two outcomes. However, 
only a few studies have considered mean duration of 
mechanical ventilation, mean ICU stay and hospital 
mortality, and funnel-plot analysis could not be done: 
the presence of publication bias could not, therefore, 
be excluded for these three outcomes. Fifth, we were 
unable to perform an adjusted analysis accounting for 
difference in baseline characteristics and concomitant 
risk factors (other than DVT) that may contribute to 
length of stay and mortality among critically ill patients 
since the contributing studies did not uniformly present 
data required for such an analysis. This may have led 
to an overestimate of the WMD and RR estimates 
for these outcomes. Sixth, our study assumes that 
ultrasonography is the reference standard for the 
diagnosis of DVT in critically ill patients; although 
the reliability of ultrasonography in the ICU has not 
been tested, it is the dominant method of screening 
and diagnosis in this setting27. Finally, we cannot 
conclude that DVT is an independent risk factor for 
poor outcomes in ICU patients because we did not 
obtain individual patients' data from single studies. 
Despite these limitations, the findings of the present 
meta-analysis are clinically important, at least insofar 
as they highlight the (largely undiagnosed) burden of 
disease attributable to VTE in critically ill patients. 
They point to the need for further studies in this area, 
and to the need for more effective strategies to prevent, 
diagnose and manage DVT in critically ill patients.
Conclusions
In summary, to the best of our knowledge, this is 
the first systematic review and meta-analysis of the 
literature investigating the effects of DVT in critically ill 
patients. Although the strength of our conclusions about 
the impact of DVT on critically ill patients is limited 
by the quality of the contributing data and the paucity 
of eligible studies with control subjects, it is clear that 
patients who experience DVT have significantly higher 
rates of morbid outcomes, highlighting the need for 
further research in this area. 
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